Elastic Vesicles, Stronger Defense: Transferosome Gel as a Game-changer in Skin Fungal Therapy

Skin is the largest organ in the human body. Millions of people around the world are suffering from fungal skin infections. This condition also disrupts their daily routines. Dermatophytes and Candida are the most common causes of fungal illnesses. Antifungal agents such as azoles, polyenes, allylamines, and echinocandins are used to prepare topical anti-fungal medication. Nowadays, topical antifungal treatments like ointments and creams face challenges such as patient compliance issues and poor skin penetration. Transferosome gels emerge as a promising alternative for treating skin fungal infections by improving solubility, permeability, and controlled release of antifungal agents, and transferosomes are more elastic and flexible than other vesicular delivery systems. Key components of transferosome gel formulation include phospholipids and edge activators, which minimise side effects, improve skin penetration, and create an efficient drug delivery system. Considering problems with stability and formulation cost, Transferosome gel provides a novel, efficient, and patient-friendly treatment for fungal infection. Although the method has shown potent antifungal properties, it is still lacking in proper assessment, data on long-term stability, and clinical credibility, thus making it less translatable into a clinical setup. Transferosome gel offers significant improvement over traditional treatment and warrants further research and clinical development to fully realize its therapeutic potential.